Clinical Trials 
BMT Clinical Trials - Updated January 15, 2010
- NSH 721 – NMDP Recipient Consent for Participation in Registry, Research Database, and Research Sample Repository
- NSH 747 – A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for patients with Hematologic Malignancies
- NSH 756 – Reduced Intensity Allogeneic Stem Cell Transplantation with Matched Unrelated Donors for Patients with Hematologic Malignances
- NSH 807 – Pre-administration of Rabbit ATG to Optimize Donor T-Cell Engraftment Following Reduced Intensity Allogeneic PBSCT from Matched-Related Donors
- NSH 864 – A Phase II trial of Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients with Hematologic Malignancies
- NSH 865 – A Multi-Center, Phase II Trail of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients with Hematologic Malignancies
- NSH 871 – Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell Lymphoma following Autologous Stem Cell Transplant.
- 877 CORD – A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy
Leukemia Clinical Trials - Updated January 15, 2010
- NSH 825 – A Phase I/II Trial of the Combination Vidaza and Mylotarg Therapy for Treatment of Relapsed AML
- NSH 850 – Phase III Open-Label Randomized Study of Amonafide L-Malate in Combination with Cytarabine compared to Daunorubicin in Combination with Cytarabine in Patients with Secondary AML
